The tirzepatide before and after results and comparable retatrutide data suggest that the glucagon receptor component produces additional fat loss beyond what dual agonist therapy achieves, particularly for visceral fat
Both are injectable medications used to manage T2DM, but they belong to different classes 2 , 5 : -Ozempic is a brand name for the drug semaglutide, which is a GLP-1 receptor agonist that activates one hormone pathway
Common side effects (minimal) Most people: No side effects GHK-Cu extremely well-tolerated Natural peptide (found in body) Minimal adverse effects Possible minor effects: Injection site stinging (common, harmless) Minor bruising at injection sites Slight blue tint to injection site (copper, temporary) Mild headache (rare) Managing side effects: Stinging: Inject slowly, warm peptide to room temp Bruising: Rotate sites, proper technique Blue tint: Normal, fades within days Headache: Hydrate well, reduce dose Contraindications and cautions Avoid if: Pregnancy or breastfeeding (no data) Active cancer (theoretical copper concerns) Wilson's disease (copper metabolism disorder) Hemochromatosis (iron overload, copper caution) Use caution with: Copper supplements (avoid taking both) High copper foods (monitor intake) Liver disease (copper metabolism) Generally safe for: All ages (adults) Men and women Long-term use Most health conditions Copper toxicity concerns Is copper in GHK-Cu dangerous
S-palmitoyl coenzyme
A lot of the peptide market depends on people blurring those lines
